$Myovant Sciences(MYOV)$ Myovant Sciences (NYSE:MYOV) is up in first action since disclosing in a filing that Roivant Sciences agreed to buy 3.5M shares of Myovant from Millennium Pharma.That agreement came on Monday, according to the filing.It brings Roivant's stake in Myovant to 49.7%.